Sep 25, 2025
931:901
For every 901 shares held, investors received 931. The price per share adjusted from $21.10 to $20.42.
The split itself did not change the total investment value.
Andros Pharmaceuticals Co., Ltd. (TPEX:6917) operates in the Pharmaceuticals: major industry.
Andros Pharmaceuticals Co., Ltd. company overviewAndros Pharmaceuticals Co., Ltd.'s most recent stock split was on September 25, 2025. It was a 931-for-901 forward split, so shareholders received 931 shares for every 901 they held.
Andros Pharmaceuticals Co., Ltd. (TPEX:6917) has split its stock 2 times: a 194-for-183 split on July 18, 2023 and a 931-for-901 split on September 25, 2025.
Andros Pharmaceuticals Co., Ltd. has split its stock 2 times. This history records 2 forward splits between July 18, 2023 and September 25, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Andros Pharmaceuticals Co., Ltd.'s 931-for-901 split on September 25, 2025, every 901 shares became 931 shares.
Andros Pharmaceuticals Co., Ltd. has not announced a new split in our records. Its most recent split was on September 25, 2025, 1 year ago. Companies announce splits in advance, and any new TPEX:6917 split will appear on this page.
Already premium?